pSivida develops drugs used to treat eye diseases.

pSivida to raise $US16m

Biotech company pSivida has released details of its $16 million capital raising which will be used to advance its drug products which treat eye diseases.


(existing subscribers)

The password field is case sensitive.
Request new password

Add your comment

BNiQ Disclaimer